isomethyleugenol has been researched along with Lymphopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Lin, J; Yang, F | 1 |
| Almanzar, G; Benoit, S; El Hajj, N; Goebeler, M; Haaf, T; Hamm, H; Hilligardt, D; Klein, M; Kneitz, H; Prelog, M; Rosenwald, A; Schmalzing, M; Tony, HP; Wild, V | 1 |
1 review(s) available for isomethyleugenol and Lymphopenia
| Article | Year |
|---|---|
Post-translational modifications in T cells in systemic erythematosus lupus.
Topics: Acetylation; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Glycosylation; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphopenia; Methylation; Phosphorylation; Protein Processing, Post-Translational; Signal Transduction; Sumoylation; Ubiquitination | 2021 |
1 other study(ies) available for isomethyleugenol and Lymphopenia
| Article | Year |
|---|---|
Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis.
Topics: Adult; Aged; Antigens, Surface; Biomarkers; Cytokines; DNA Methylation; Female; Forkhead Transcription Factors; Humans; Immunomodulation; Lymphocyte Count; Lymphopenia; Male; Methylation; Middle Aged; Nuclear Receptor Subfamily 1, Group F, Member 3; Scleroderma, Systemic; T-Lymphocytes, Regulatory; Th17 Cells | 2016 |